Usage Pattern of Antibiotics for Management of Pneumonia

Authors

  • Lata Khani Bisht Assistant professor, T John College of Pharmacy, Gottigere, Bangalore, Karnataka, India
  • Vineeth Chandy Principal, T John College of Pharmacy, Gottigere, Bangalore, Karnataka, India

Keywords:

Pneumonia, antibiotic, spectrum, prescription pattern

Abstract

Abstract

Pneumonia has evolved as one of the deadly infections globally and is a cause of concern all over the world. It is an air borne infection affecting the alveoli of the lungs and is caused by virus, bacteria, fungus etc. Antibiotic therapy is the most commonly available therapy in cases of pneumonia. Hence analysis of prescribing pattern of narrow and broad-spectrum antibiotics in pneumonia patients is essential for better treatment of disease. The study also aimed at prescription pattern across different age groups namely paediatrics, adults and elderly. The patients were also analysed based on sex, smoking habits and co-morbidities. The development of drug resistant pneumonia is a cause of concern in a long run.   This study was conducted in a multi-speciality hospital among 225 patients.

 

Keywords: Antibiotic, Pneumonia, prescription pattern, respiratory tract infection, spectrum

 

Cite this Article

Lata Khani Bisht, Vineeth Chandy. Usage Pattern of Antibiotics for Management of Pneumonia. Research & Reviews: A Journal of Pharmacology. 2020; 10(2): 15–19p

Author Biography

  • Lata Khani Bisht, Assistant professor, T John College of Pharmacy, Gottigere, Bangalore, Karnataka, India

    ASSISTANT PROFESSOR,

    PHARMACEUTICAL CHEMISTRY DEPARTMENT,

    T JOHN COLLEGE OF PHARMACY,

    BANGALORE

References

Mizgerd JP. Acute lower respiratory tract infection. N Engl J Med 2008;358:716–727.

Wunderink RG, Mutlu GM. Pneumonia: overview and epidemiology. In: Laurent GJ, Shapiro SD, eds. Encyclopedia of Respiratory Medicine. Oxford, UK: Elsevier Academic Press; 2006:402–410.

Chalmers J, Campling J, Ellsbury G, Hawkey PM, Madhava H, Slack M. Community-acquired pneumonia in the United Kingdom: a call to action. Pneumonia. 2017;9(1):15.

Chalmers JD, Campling J, Dicker A, Woodhead M, Madhava H. A systematic review of the burden of vaccine preventable pneumococcal disease in UK adults. BMC Pulm Med. 2016;16(1):77.

Barlow G, Nathwani D, Davey P. The CURB65 pneumonia severity score outperforms generic sepsis and early warning scores in predicting mortality in community-acquired pneumonia. Thorax. 2007;62(3):253–9.

Lim WS, Baudouin SV, George RC, Hill AT, Jamieson C, Le Jeune I, et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax. 2009;64(Suppl 3):iii1–55.

Chalmers JD, Mandal P, Singanayagam A, Akram AR, Choudhury G, Short PM, et al. Severity assessment tools to guide ICU admission in community-acquired pneumonia: systematic review and meta-analysis. Intensive Care Med. 2011;37(9):1409–20.

Sharma S, Sethi GR, Gupta U. Standard Treatment Guidelines: A Manual for Medical Therapeutics. 3rd ed. New Delhi: BI Publications; 2009. Delhi Society for Promotion of Rational Use of Drugs. Acute diarrhea; pp. 119–20.

Ganguly NK, Arora NK, Chandy SJ, Fairoze MN, Gill JP, Gupta U, et al. Rationalizing antibiotic use to limit antibiotic resistance in India. Indian J Med Res. 2011;134:281–94.

Bosso JA, Drew RH. Application of antimicrobial stewardship to optimise management of community acquired pneumonia. Int J Clin Pract. 2011;65:775–83.

Gupta D, Agarwal R, Aggarwal AN, Singh N, Mishra N, Khilnani GC, et al. Guidelines for diagnosis and management of community- and hospital-acquired pneumonia in adults: Joint ICS/NCCP(I) recommendations. Lung India. 2012;29(Suppl 2):S27–62.

Downloads

Published

2020-09-22

Issue

Vol. 10 No. 2 (2020)

Section

Case Study

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.